From Julius Wagner-Jauregg to biomarkers and immunological therapies

World Journal of Biological Psychiatry

Volumn 11, Issue 2, 2010, Pages 154-155

  Himmerich, Hubertus ^a   Kirkby, Kenneth Clifford ^b   Steinberg, Holger ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF TASMANIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR;

FEVER; IMMUNE RESPONSE; IMMUNOTHERAPY; LETTER; MENTAL DISEASE; NEUROSYPHILIS; PSYCHOSIS; SCHIZOPHRENIA; TH1 CELL; TH2 CELL;

BIOLOGICAL MARKERS; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; IMMUNOTHERAPY; INFECTION; MENTAL DISORDERS;

EID: 77649127027     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622970903559933     Document Type: Letter

References (4)

1. Müller N, Riedel M, Scheppach C, Brandstätter B, Sokullu S, Krampe K, et al. 2002. Benefi cial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia. Am J Psychiatry 159:1029-1034.
2. Stöber G, Ben-Shachar D, Cardon M, Falkai P, Fonteh AN, Gawlik M, et al. 2009. Schizophrenia: from the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markers. World J Biol Psychiatry 10:127-155.
3. Wagner-Jauregg J. 1887. Ueber die Einwirkung fi eberhafter Erkrankungen auf Psychosen. Jb Psychiat 7:94-131.
4. Zetterström M, Sundgren-Andersson AK, Ostlund P, Bartfai T. 1998. Delineation of the proinflammatory cytokine cascade in fever induction. Ann NY Acad Sci 856:48-52.